Isolated cerebral Mucormycosis and Aspergillosis coinfection in an immunocompromised adult

BMJ Case Rep. 2023 Aug 27;16(8):e255909. doi: 10.1136/bcr-2023-255909.

Abstract

Opportunistic fungal infections are a major cause of mortality in immunosuppressed patients, with mucormycosis and aspergillosis as two of the most commonly identified fungal organisms. Coinfection with mucormycosis and aspergillosis is rare, but cases have been reported in literature, most commonly presenting as disseminated invasive fungal infection with cerebrorhino-orbital involvement in an immunocompromised patient. Infections are most commonly caused by direct implantation of spores with localised angioinvasion. Haematogenous spread is rare, with most cases secondary to haematological malignancies or intravenous drug use. Coinfection with mucormycosis and aspergillosis portends a poor prognosis, with a high mortality rate. Thus, prompt recognition and intervention are crucial to prevent poor outcomes. In this unique case report, we describe a case of isolated cerebral mucormycosis and aspergillosis coinfection, not previously reported in literature.

Keywords: Infection (neurology); Neuroimaging.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Aspergillosis*
  • Coinfection*
  • Hematologic Neoplasms*
  • Humans
  • Immunocompromised Host
  • Invasive Fungal Infections*
  • Mucormycosis* / complications
  • Mucormycosis* / diagnosis
  • Mucormycosis* / drug therapy